TY - JOUR
T1 - Designing genetic studies for people with intellectual disabilities
T2 - Practical lessons from a pilot study
AU - Sellers, Adrian
AU - Hudson, Sharon
AU - Ledger, Joanna
AU - Moorehouse, Charlotte
AU - Young, Charlotte
AU - Groeber, Ian
AU - Knight, Bridget
AU - Mill, Jonathan
AU - Allard, Jon
AU - Shankar, Rohit
N1 - Publisher Copyright:
© 2022 The Authors. Journal of Policy and Practice in Intellectual Disabilities published by International Association for the Scientific Study of Intellectual and Developmental Disabilities and Wiley Periodicals LLC.
PY - 2023/10/11
Y1 - 2023/10/11
N2 - Genetic variations are overrepresented in people with intellectual disability (PwID), particularly those with physical and mental health co-morbidities, but remain significantly under-diagnosed. Lack of suitable research studies, a natural extension of the complexities posed of consenting and recruitment is considered culpable. There is a resultant dearth of evidence on establishing bespoke genetic studies for adult PwID. This report outlines the challenges faced in the implementation and administration of a pilot genetic study for adult PwID hoping to better inform future genetic study designs for PwID. Adult participants with a diagnosis of ID (ICD10 F70-F73) and epilepsy (ICD10 G40) were recruited to The Peninsula study exploring genomic stratification in intellectual disability and epilepsy via the ethically approved Royal Devon and Exeter Tissue Bank (RDETB) (16/SC/016). Managed within the National Institute for Health Research (NIHR) Exeter Clinical Research Framework, the RDETB was set up to proactively collect and store ‘spare’ tissue from routine clinical procedures such as venepunctures for routine good practice biochemistry monitoring. Participants who satisfied the criteria for the need for routine bloods to monitor their general health were identified to be invited for participation. From October 2017 to March 2020 from a total caseload of 375 PwID and epilepsy, 291 were screened (77.6%), 116 (39.9%) identified as potentially eligible and sent study information and genetic samples obtained from 30 (8%). Analysis showed 75% of PwID had some biochemical abnormalities requiring further medical attention. The recruitment was influenced by the clinical care set up in implementing the sanctioned ethics. However, where bloods were achieved it proved to be beneficial in identifying hitherto undiagnosed medical problems. While the challenges to gain consent, are considerable, the reasonable adjustments needed to facilitate participation and the immediate clinical benefits where engagement was successful are significant.
AB - Genetic variations are overrepresented in people with intellectual disability (PwID), particularly those with physical and mental health co-morbidities, but remain significantly under-diagnosed. Lack of suitable research studies, a natural extension of the complexities posed of consenting and recruitment is considered culpable. There is a resultant dearth of evidence on establishing bespoke genetic studies for adult PwID. This report outlines the challenges faced in the implementation and administration of a pilot genetic study for adult PwID hoping to better inform future genetic study designs for PwID. Adult participants with a diagnosis of ID (ICD10 F70-F73) and epilepsy (ICD10 G40) were recruited to The Peninsula study exploring genomic stratification in intellectual disability and epilepsy via the ethically approved Royal Devon and Exeter Tissue Bank (RDETB) (16/SC/016). Managed within the National Institute for Health Research (NIHR) Exeter Clinical Research Framework, the RDETB was set up to proactively collect and store ‘spare’ tissue from routine clinical procedures such as venepunctures for routine good practice biochemistry monitoring. Participants who satisfied the criteria for the need for routine bloods to monitor their general health were identified to be invited for participation. From October 2017 to March 2020 from a total caseload of 375 PwID and epilepsy, 291 were screened (77.6%), 116 (39.9%) identified as potentially eligible and sent study information and genetic samples obtained from 30 (8%). Analysis showed 75% of PwID had some biochemical abnormalities requiring further medical attention. The recruitment was influenced by the clinical care set up in implementing the sanctioned ethics. However, where bloods were achieved it proved to be beneficial in identifying hitherto undiagnosed medical problems. While the challenges to gain consent, are considerable, the reasonable adjustments needed to facilitate participation and the immediate clinical benefits where engagement was successful are significant.
KW - genetics
KW - intellectual disabilities
KW - mental capacity
KW - practice
KW - research
UR - http://www.scopus.com/inward/record.url?scp=85140079388&partnerID=8YFLogxK
UR - https://pearl.plymouth.ac.uk/context/pms-research/article/2151/viewcontent/Policy_Practice_Intel_Disabi___2022___Sellers___Designing_genetic_studies_for_people_with_intellectual_disabilities_.pdf
U2 - 10.1111/jppi.12445
DO - 10.1111/jppi.12445
M3 - Article
AN - SCOPUS:85140079388
SN - 1741-1122
VL - 20
SP - 158
EP - 163
JO - Journal of Policy and Practice in Intellectual Disabilities
JF - Journal of Policy and Practice in Intellectual Disabilities
IS - 2
ER -